BioMedSA is thrilled to announce the successful launch of BioMarketSATM, an innovative program designed to accelerate the commercialization of healthcare and bioscience solutions. This initiative brought together 7 promising startups from across the country for an intensive bootcamp, culminating in mock pitch presentations to experienced members of Value Analysis Committees (VACs) at multiple hospitals—the very professionals who guide hospitals in evaluating and adopting new technologies. Our thanks to University Health, UT Health San Antonio, Methodist Healthcare, and Orlando Health.
The feedback from VAC participants was nothing short of exceptional. The insights they shared were specific, actionable, and deeply valuable, helping startups understand the critical decision-making process hospitals use when considering new innovations. This real-world perspective is what makes BioMarketSATM unique—bridging the gap between groundbreaking ideas and practical adoption in healthcare systems.
We are proud to have partnered with Cogent Consults VACReady BootcampTM to deliver this program, ensuring participants received expert guidance throughout the journey.
Planning is already underway for the next iteration of BioMarketSATM in 2026. If you’re interested in being part of this transformative program or want to stay informed about upcoming announcements, click to sign up for updates. BioMarketSA 2026
Learn more about BioMarketSATM and its purpose on our website. https://biomedsa.org/biomarketsa/